RNA-sequencing of CD۴+ T cells in Relapsing-Remitting Multiple Sclerosis patients at relapse; deciphering the involvement of novel genes and pathways

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 166

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

IBIS10_006

تاریخ نمایه سازی: 5 تیر 1401

چکیده مقاله:

CD۴+ T cells known as a noteworthy potential modulator of inflammation in multiple sclerosis (MS). In thecurrent study, we investigated the transcriptome profile of CD۴+ T cells in relapsing-remitting MS (RRMS)patients at relapse phase. We performed RNA sequencing of CD۴+ T cells isolated from RRMS patients atrelapse phase and age- and sex-matched healthy controls. The edgeR statistical method was employed todetermine differential expression genes (DEGs). The gene set enrichment analysis was subsequentlyperformed. Applying physical interaction network, genes with higher degrees were selected as hub genes.A total of ۱۲۷۸ genes and ۱۰۳۴ gens were defined at significantly higher or lower levels, respectively, inCD۴+ T cells of RRMS patients at relapse phase as compared with healthy controls. The top up- and downregulatedgene were JAML and KDM۳A. The detected DEGs were remarkably on chromosomes ۱ and ۲,respectively. The DEGs were mainly enriched in pathways such as ‘regulation of transcription, DNAtemplated’,‘regulation of B cell receptor signaling pathway’, ‘protein phosphorylation’, ‘epidermal growthfactor receptor signaling pathway’, and ‘positive regulation of neurogenesis’. Moreover, ۱۶ KEGG pathwaysmostly associated with the immune system and viral infections were enriched. In the constructed physicalinteraction networks, UBA۵۲ and TP۵۳ were illustrated as the most highly ranked hub genes among up- anddown-regulated genes, correspondingly.Conclusions: By applying global transcriptome profiling of CD۴+ T cells, we deciphers the involvement ofseveral novel genes and pathways in MS pathogenesis. The present results need to be affirmed by in vivoand in vitro studies.

نویسندگان

Zahra Salehi

Immunology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Saeed Talebi

Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran-Department of Pediatrics, Faculty of Medicine, Ali Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran.

Samaneh Maleknia

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Fahimeh Palizban

Laboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran

Abdorreza Naser Moghadasi

MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Kaveh Kavousi

Laboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran